R
ift Valley fever (RVF) epidemics occur at irregular intervals in Africa, on the Arabian Peninsula, in Madagascar, and on other Indian Ocean islands (1) . South Africa has experienced 3 major epidemics during 1950-1951, 1974-1976, and 2008-2011 , with smaller sporadic outbreaks in between (2, 3) . Phylogenetic analyses of isolates spanning 70 years have shown widespread dispersal of RVF virus (RVFV) genotypes throughout the regions where the virus is endemic and a high level of diversity within small geographic areas (4, 5) . We report the laboratory confirmation of 8 RVF cases in humans in South Africa in 2018 and phylogenetic analysis of the virus responsible for the outbreak.
The Study
Communicable disease surveillance and outbreak investigation activities of the National Institute for Communicable Diseases (Johannesburg, South Africa) are approved by the Human Research Ethics Committee of the University of the Witwatersrand, Johannesburg, South Africa (M160667). In mid-May 2018, an outbreak of RVF in sheep on a farm in Free State Province, South Africa, was reported, followed by 4 probable cases in humans detected by RVFV serology (6) . The affected farm is located in Jacobsdal District, a farming community close to the border of Northern Cape Province, where sheep are the main livestock species. In addition to the 6 patients sampled on May 21, 2018, described previously (6), another 4 were sampled on June 4, 2018. These patients experienced headache, muscle pain, fever, body ache, rigors, and nausea, as reported previously (6) . A recent history of influenza-like illness was reported for only 2 of these 4 patients. All 4 lived and worked on the farm and were involved in high-risk activities, such as slaughtering, autopsying, disposal and burial of carcasses, or handling of raw meat. We obtained followup samples from all 10 patients for paired serologic testing (Appendix Table 1 , https://wwwnc.cdc.gov/EID/ article/25/2/18-1289-App1.pdf).
We performed the serologic assays, hemagglutination inhibition assay, virus neutralization test, and IgM ELISA with all serial serum samples collected from all 10 patients (7) and real-time reverse transcription PCR (RT-PCR) (8) on the serum fractions of clotted blood collected from the first 6 patients with suspected cases described previously (6) . We extracted nucleic acid from EDTA whole blood samples collected from the initial 4 patients with probable cases using the MagMax Pathogen RNA/DNA Kit (Applied Biosystems, https://www.thermofisher.com) and then tested by RT-PCR. We determined the partial genome sequences of viruses from RT-PCR-positive whole blood samples using sequence-independent single-primer amplification combined with sequencing in triplicate on an Illumina MiSeq (https://www.illumina.com) and raw data processing, as described previously (9) . After quality and host filtering and using a requirement of >3× coverage per base, we mapped raw reads to reference sequences representing the RVFV large (L), medium (M), and small (S) segments (GenBank accession nos. KX611605-7). We concatenated sequence fragments of segments, prepared alignments in MEGA6 (https://www.megasoftware.net), performed phylogenetic analyses using RAxML version 8.2.10 (http:// evomics.org/learning/phylogenetics/raxml), and visualized trees with Figtree version 1.4.3 (http://tree.bio.ed.ac.uk/ software/figtree).
Of 10 patients sampled, 8 seroconverted after 2 or 3 serial bleeds, as evidenced by a 4-fold increase in the hemagglutination inhibition assay or virus neutralization test titers (Appendix Table 1 ), and had RVFV-specific IgM, confirming their recent RVFV infection status. We detected RVFV RNA in EDTA whole blood samples of 3 of 4 patients sampled 7 days after estimated symptom onset (Appendix Table 1 ). Sequence-independent singleprimer amplification sequencing yielded sequence fragments of the M and L segments in 1 (SA344-18) of 3 samples (GenBank accession nos. MH753234-41). We concatenated these partial sequence fragments (Appendix Table 3 ) and a separate alignment with a 490-nt portion of the M segment of SA344-18 and sequences available from GenBank from a previous study, including sequences from the 2010 RVF outbreak in South Africa (5).
In phylogenetic analyses of the L and M segments, isolate SA344-18 grouped with lineage E (Figure 1 ; Appendix Figure 1 ), according to the lineage nomenclature of Bird et al. (4) . In analyses of all segments, this RVFV isolate had the closest relationship to Beijing-01, an isolate from a 2016 case exported to China from Angola (10), and to a 2009 sheep isolate from Kakamas, Northern Cape Province, South Africa (11) (Figures 1, 2; Appendix Figures 1, 2) . The E lineage also included 25010-24, an isolate from a camel sampled during an outbreak in Mauritania in 2010 (Appendix Figure 1) (11) . Nodes of the partial S segment tree were poorly supported, probably because the fragments were small (Appendix Figure 2) . The overall pairwise nucleotide differences were 3.1% for L, 3.6% for M, and 3.1% for S (nonstructural protein gene), similar to values reported previously (4, 5) .
According to the partial 490-nt M segment tree and lineage nomenclature of Grobbelaar et al. (5), SA344-18 is lineage K (Figure 2 ). All 2010 RVFV sequences from humans in South Africa, except SA184-10, group in lineage H, distant from SA344-18. Isolate SA184-10 (lineage K) was obtained from a patient who had a needle-stick injury These isolates group in the lineage that includes Smithburn vaccine viruses and its parent strain, Entebbe, isolated in Uganda in 1944 (4) . Camel isolate 25010-24 also falls in this lineage, despite most other RVFV isolates from Mauritania grouping with distant lineages (11) .
Intensified surveillance during interepidemic periods would enhance our knowledge of the genetic evolution of RVFV. Isolated outbreaks, similar to the one reported here, probably have occurred more frequently than recorded. Establishment of sentinel herds of susceptible animals and increased vector surveillance could yield isolates more frequently and lead to a better characterization of the strains maintained at low levels between epidemics. Our results indicate an ongoing activity and evolution of RVFV during interepizootic periods and highlight the importance of a cryptic transmission cycle that enables establishment of endemicity, which at times inevitably emerges in the form of an explosive outbreak.
